Major bleeding in users of direct oral anticoagulants in atrial fibrillation: a pooled analysis of results from multiple population‐based cohort studies

HA van den Ham, PC Souverein… - … and Drug Safety, 2021 - Wiley Online Library
Objective To establish the risk of major bleeding in direct oral anticoagulant (DOAC) users
(overall and by class) versus vitamin K antagonist (VKA) users, using health care databases …
被引用次数：21 相关文章

[引用][C] Major bleeding in users of direct oral anticoagulants in atrial fibrillation: A pooled analysis of results from multiple population-based cohort studies

HA van den Ham, PC Souverein… - … and Drug Safety, 2021 - produccioncientifica.ucm.es
Major bleeding in users of direct oral anticoagulants in atrial fibrillation: A pooled analysis of
results from multiple population-based cohort studies | Documentos - Universidad …
[PDF] cnodes.ca

[PDF][PDF] Major bleeding in users of direct oral anticoagulants in atrial fibrillation: A pooled analysis of results from multiple population-based cohort studies

HA van den Ham, PC Souverein, OH Klungel, RW Platt… - drugs, 2021 - cnodes.ca
Objective: To establish the risk of major bleeding in direct oral anticoagulant (DOAC) users
(overall and by class) versus vitamin K antagonist (VKA) users, using health care databases …

Major bleeding in users of direct oral anticoagulants in atrial fibrillation: A pooled analysis of results from multiple population-based cohort studies.

HA van den Ham, PC Souverein… - … and Drug Safety, 2021 - europepmc.org
Objective To establish the risk of major bleeding in direct oral anticoagulant (DOAC) users
(overall and by class) versus vitamin K antagonist (VKA) users, using health care databases …
[HTML] nih.gov

[HTML][HTML] Major bleeding in users of direct oral anticoagulants in atrial fibrillation: A pooled analysis of results from multiple population‐based cohort studies

HA van den Ham, PC Souverein… - … and Drug Safety, 2021 - ncbi.nlm.nih.gov
Objective To establish the risk of major bleeding in direct oral anticoagulant (DOAC) users
(overall and by class) versus vitamin K antagonist (VKA) users, using health care databases …

Major bleeding in users of direct oral anticoagulants in atrial fibrillation: A pooled analysis of results from multiple population-based cohort studies

HA Ham, PC Souverein, OH Klungel… - … and Drug Safety, 2021 - epub.ub.uni-muenchen.de
Objective To establish the risk of major bleeding in direct oral anticoagulant (DOAC) users
(overall and by class) versus vitamin K antagonist (VKA) users, using health care databases …

Major bleeding in users of direct oral anticoagulants in atrial fibrillation: A pooled analysis of results from multiple population-based cohort studies

HA van den Ham, PC Souverein… - … and drug safety, 2021 - pubmed.ncbi.nlm.nih.gov
Objective To establish the risk of major bleeding in direct oral anticoagulant (DOAC) users
(overall and by class) versus vitamin K antagonist (VKA) users, using health care databases …

Major bleeding in users of direct oral anticoagulants in atrial fibrillation: A pooled analysis of results from multiple population-based cohort studies Research output …

Pharmacoepidemiology and Drug Safety, 2021 - drug.ku.dk
van den Ham, HA, Souverein, PC, Klungel, OH, Platt, RW, Ernst, P, Dell'Aniello, S, Schmiedl,
S, Grave, B, Rottenkolber, M, Huerta, C, Martin Merino, E, Leon-Munoz, LM, Montero, D …

Major bleeding in users of direct oral anticoagulants in atrial fibrillation: A pooled analysis of results from multiple population-based cohort studies.

HA van den Ham, PC Souverein… - … and Drug Safety, 2021 - europepmc.org
Objective To establish the risk of major bleeding in direct oral anticoagulant (DOAC) users
(overall and by class) versus vitamin K antagonist (VKA) users, using health care databases …